Webinar: Optimization of Design Transfer from Device Development to Final assembly
SHL Medical will hold a webinar hosted by Pharmafile on February 24 at 3:00 PM UK. The webinar will be presented by Taras Seniuch, SHL’s Head of Account Management, Americas and Amy Hartl, SHL’s Director of Process Development. The presentation will be followed by a live Q&A session where attendees can come forward with their questions and have an interactive discussion with the speakers.
In this webinar, Taras and Amy will discuss the importance of design transfer within the overall autoinjector development framework and provide further insight into key factors that need to be considered for effective design transfer processes. Additionally, the speakers will explore different final assembly options and discuss the differences, risks, and advantages related to each option, highlighting SHL’s integrated process development approach to ensure effective transfer from development into commercialization.
Key topics that will be covered include:
- Design transfer in the drug delivery device industry
- Critical factors to consider in the design transfer processes
- Comparison of different final assembly options
- SHL Medical’s process development strategy and capabilities
To fully explore SHL Medical’s capabilities and expertise, we offer an enhanced experience through a simple and intuitive interface. Visit the SHL Experience webpage and gain a better understanding of SHL Medical as a whole.
Meet the presenters
|
|
Taras Seniuch Head of Account Management, Americas, SHL Medical Taras Seniuch has been working in SHL since 2016. As Head of Account Management, Americas, Taras focuses on SHL’s device development and contract manufacturing offerings and services. Prior to joining SHL, Taras worked for global companies such as Sanofi, Amgen, and Vertex Pharmaceuticals. He has held a number of different roles across these organizations, including primary and secondary container development, device development, and international supply chain.
|
|
|
Amy Hartl Director of Process Development, SHL Medical Dr. Amy Hartl has been working at SHL since 2016. As Director of Process Development, Dr. Hartl oversees the operations, testing, and statistical analyses that are crucial for the successful design transfer of autoinjector devices from development to commercialization. The process development team develops, validates, and transfers device testing, final assembly, device labeling, final packaging, and serialization processes. In parallel, her team also develops strategies for increasing and optimizing the site’s capacity by implementing high-speed equipment, expanding technological capabilities, and leaning out existing processes.
|
